From: Robenacoxib versus meloxicam for the control of peri-operative pain and inflammation associated with orthopaedic surgery in cats: a randomised clinical trial
Groups
Number of cats
s.c. dosage (mean ± SD) in mg/kg
Daily oral dosage (mean ± SD) in mg/kg*
Target
Actual
Robenacoxib (s.c. + oral)
101
2.0
2.0 ± 0.09
1.0 – 2.4
1.58 ± 0.41
Meloxicam (s.c. + placebo oral)
46
0.3
0.3 ± 0.005
-